Proteomics, phosphoproteomics and kinome analysis as well as several kinase activity assessment assays established the importance of diminution JNK activity and c-KIT-AKT-mTOR axis enhancement in the establishment of RH1 resistance in the triple-negative breast cancer cells. The gene discussed is MTOR; the disease is triple-negative breast carcinoma.